2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine

C341H219N45O3S2 — CID 159855896

IUPAC2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine
SMILESCn1c(-c2ccc(-c3ccc4c(ccc5ccccc54)c3)cc2)nc2ccccc21.Cn1c(-c2cccc(-c3ccc4c(ccc5ccccc54)c3)n2)nc2ccccc21.Cn1cnc2ccc(-c3ccc(-c4ccc5c(ccc6ccccc65)c4)cc3)cc21.Cn1cnc2ccc(-c3cccc(-c4ccc5c(ccc6ccccc65)c4)n3)cc21.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncoc3c2)c1.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncsc3c2)c1.c1ccc(-c2ncnc(-c3ccc4c(c3)cc(-c3ncnc(-c5ccccn5)n3)c3ccc(-c5ncnc(-c6ccccn6)n5)cc34)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5cc(-c6ncnc(-c7ccccn7)n6)ccc54)c3)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5ccc(-c6ncnc(-c7ccccn7)n6)cc54)c3)n2)nc1.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncoc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncsc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4nc5ccccc5o4)cc3)ccc12
InChIInChI=1S/C38H22N12.2C30H18N8.2C28H20N2.2C27H19N3.2C27H17NO.C27H17NS.C26H16N2O.C26H16N2S/c1-4-14-39-30(7-1)36-45-20-42-33(48-36)23-10-12-26-25(17-23)19-29(35-44-22-47-38(50-35)32-9-3-6-16-41-32)27-13-11-24(18-28(26)27)34-43-21-46-37(49-34)31-8-2-5-15-40-31;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-11-12-23-20(15-21)9-7-19-8-10-22(16-24(19)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-9-11-23-19(15-21)7-8-20-16-22(10-12-24(20)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-30-27-9-5-4-8-26(27)29-28(30)21-13-10-19(11-14-21)22-16-17-25-23(18-22)15-12-20-6-2-3-7-24(20)25;1-30-18-29-27-15-13-23(17-28(27)30)20-8-6-19(7-9-20)22-12-14-26-24(16-22)11-10-21-4-2-3-5-25(21)26;1-30-26-12-5-4-9-24(26)29-27(30)25-11-6-10-23(28-25)20-15-16-22-19(17-20)14-13-18-7-2-3-8-21(18)22;1-30-17-28-26-14-12-21(16-27(26)30)25-8-4-7-24(29-25)20-11-13-23-19(15-20)10-9-18-5-2-3-6-22(18)23;1-2-6-23-19(5-1)11-14-22-17-21(15-16-24(22)23)18-9-12-20(13-10-18)27-28-25-7-3-4-8-26(25)29-27;2*1-2-4-24-20(3-1)9-10-23-15-21(11-13-25(23)24)18-5-7-19(8-6-18)22-12-14-26-27(16-22)29-17-28-26;2*1-2-5-21-17(4-1)8-9-18-14-19(10-12-22(18)21)23-6-3-7-24(28-23)20-11-13-25-26(15-20)29-16-27-25/h1-22H;2*1-18H;2*2-18H,1H3;2*2-17H,1H3;3*1-17H;2*1-16H
InChIKeyNQNGRIYMJQDVHZ-UHFFFAOYSA-N
MW5058.95 g/mol
LogP83.09
Rot. Bonds32

About 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine

2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine (PubChem CID 159855896) has the molecular formula C341H219N45O3S2 and a molecular weight of 5058.95 g/mol. Its IUPAC name is 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine.

Molecular Properties

Compound Name2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine
PubChem CID159855896
Molecular FormulaC341H219N45O3S2
Molecular Weight5058.95 g/mol
Exact Mass5054.78
IUPAC Name2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine
SMILESCn1c(-c2ccc(-c3ccc4c(ccc5ccccc54)c3)cc2)nc2ccccc21.Cn1c(-c2cccc(-c3ccc4c(ccc5ccccc54)c3)n2)nc2ccccc21.Cn1cnc2ccc(-c3ccc(-c4ccc5c(ccc6ccccc65)c4)cc3)cc21.Cn1cnc2ccc(-c3cccc(-c4ccc5c(ccc6ccccc65)c4)n3)cc21.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncoc3c2)c1.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncsc3c2)c1.c1ccc(-c2ncnc(-c3ccc4c(c3)cc(-c3ncnc(-c5ccccn5)n3)c3ccc(-c5ncnc(-c6ccccn6)n5)cc34)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5cc(-c6ncnc(-c7ccccn7)n6)ccc54)c3)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5ccc(-c6ncnc(-c7ccccn7)n6)cc54)c3)n2)nc1.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncoc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncsc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4nc5ccccc5o4)cc3)ccc12
InChIInChI=1S/C38H22N12.2C30H18N8.2C28H20N2.2C27H19N3.2C27H17NO.C27H17NS.C26H16N2O.C26H16N2S/c1-4-14-39-30(7-1)36-45-20-42-33(48-36)23-10-12-26-25(17-23)19-29(35-44-22-47-38(50-35)32-9-3-6-16-41-32)27-13-11-24(18-28(26)27)34-43-21-46-37(49-34)31-8-2-5-15-40-31;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-11-12-23-20(15-21)9-7-19-8-10-22(16-24(19)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-9-11-23-19(15-21)7-8-20-16-22(10-12-24(20)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-30-27-9-5-4-8-26(27)29-28(30)21-13-10-19(11-14-21)22-16-17-25-23(18-22)15-12-20-6-2-3-7-24(20)25;1-30-18-29-27-15-13-23(17-28(27)30)20-8-6-19(7-9-20)22-12-14-26-24(16-22)11-10-21-4-2-3-5-25(21)26;1-30-26-12-5-4-9-24(26)29-27(30)25-11-6-10-23(28-25)20-15-16-22-19(17-20)14-13-18-7-2-3-8-21(18)22;1-30-17-28-26-14-12-21(16-27(26)30)25-8-4-7-24(29-25)20-11-13-23-19(15-20)10-9-18-5-2-3-6-22(18)23;1-2-6-23-19(5-1)11-14-22-17-21(15-16-24(22)23)18-9-12-20(13-10-18)27-28-25-7-3-4-8-26(25)29-27;2*1-2-4-24-20(3-1)9-10-23-15-21(11-13-25(23)24)18-5-7-19(8-6-18)22-12-14-26-27(16-22)29-17-28-26;2*1-2-5-21-17(4-1)8-9-18-14-19(10-12-22(18)21)23-6-3-7-24(28-23)20-11-13-25-26(15-20)29-16-27-25/h1-22H;2*1-18H;2*2-18H,1H3;2*2-17H,1H3;3*1-17H;2*1-16H
InChIKeyNQNGRIYMJQDVHZ-UHFFFAOYSA-N
XLogP83.09
TPSA587.63 Ų
H-Bond Donors
H-Bond Acceptors50
Rotatable Bonds32
Heavy Atoms391
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5005058.95
LogP ≤ 583.09
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1050

Analyze 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine?
The IUPAC name of 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine (CID 159855896) is 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine.
What is the SMILES notation for 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine?
The canonical SMILES for 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine is Cn1c(-c2ccc(-c3ccc4c(ccc5ccccc54)c3)cc2)nc2ccccc21.Cn1c(-c2cccc(-c3ccc4c(ccc5ccccc54)c3)n2)nc2ccccc21.Cn1cnc2ccc(-c3ccc(-c4ccc5c(ccc6ccccc65)c4)cc3)cc21.Cn1cnc2ccc(-c3cccc(-c4ccc5c(ccc6ccccc65)c4)n3)cc21.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncoc3c2)c1.c1cc(-c2ccc3c(ccc4ccccc43)c2)nc(-c2ccc3ncsc3c2)c1.c1ccc(-c2ncnc(-c3ccc4c(c3)cc(-c3ncnc(-c5ccccn5)n3)c3ccc(-c5ncnc(-c6ccccn6)n5)cc34)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5cc(-c6ncnc(-c7ccccn7)n6)ccc54)c3)n2)nc1.c1ccc(-c2ncnc(-c3ccc4c(ccc5ccc(-c6ncnc(-c7ccccn7)n6)cc54)c3)n2)nc1.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncoc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4ccc5ncsc5c4)cc3)ccc12.c1ccc2c(c1)ccc1cc(-c3ccc(-c4nc5ccccc5o4)cc3)ccc12.
What is the InChIKey of 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine?
The InChIKey is NQNGRIYMJQDVHZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H22N12.2C30H18N8.2C28H20N2.2C27H19N3.2C27H17NO.C27H17NS.C26H16N2O.C26H16N2S/c1-4-14-39-30(7-1)36-45-20-42-33(48-36)23-10-12-26-25(17-23)19-29(35-44-22-47-38(50-35)32-9-3-6-16-41-32)27-13-11-24(18-28(26)27)34-43-21-46-37(49-34)31-8-2-5-15-40-31;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-11-12-23-20(15-21)9-7-19-8-10-22(16-24(19)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-3-13-31-25(5-1)29-35-17-33-27(37-29)21-9-11-23-19(15-21)7-8-20-16-22(10-12-24(20)23)28-34-18-36-30(38-28)26-6-2-4-14-32-26;1-30-27-9-5-4-8-26(27)29-28(30)21-13-10-19(11-14-21)22-16-17-25-23(18-22)15-12-20-6-2-3-7-24(20)25;1-30-18-29-27-15-13-23(17-28(27)30)20-8-6-19(7-9-20)22-12-14-26-24(16-22)11-10-21-4-2-3-5-25(21)26;1-30-26-12-5-4-9-24(26)29-27(30)25-11-6-10-23(28-25)20-15-16-22-19(17-20)14-13-18-7-2-3-8-21(18)22;1-30-17-28-26-14-12-21(16-27(26)30)25-8-4-7-24(29-25)20-11-13-23-19(15-20)10-9-18-5-2-3-6-22(18)23;1-2-6-23-19(5-1)11-14-22-17-21(15-16-24(22)23)18-9-12-20(13-10-18)27-28-25-7-3-4-8-26(25)29-27;2*1-2-4-24-20(3-1)9-10-23-15-21(11-13-25(23)24)18-5-7-19(8-6-18)22-12-14-26-27(16-22)29-17-28-26;2*1-2-5-21-17(4-1)8-9-18-14-19(10-12-22(18)21)23-6-3-7-24(28-23)20-11-13-25-26(15-20)29-16-27-25/h1-22H;2*1-18H;2*2-18H,1H3;2*2-17H,1H3;3*1-17H;2*1-16H.
What are the key properties of 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine?
2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine has a molecular weight of 5058.95 g/mol, XLogP of 83.09, 32 rotatable bonds, 0 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2,6-bis(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-9-yl]-4-pyridin-2-yl-1,3,5-triazine;1-methyl-2-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-6-(4-phenanthren-2-ylphenyl)benzimidazole;1-methyl-2-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;1-methyl-6-(6-phenanthren-2-yl-2-pyridinyl)benzimidazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzothiazole;2-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(4-phenanthren-2-ylphenyl)-1,3-benzoxazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzothiazole;6-(6-phenanthren-2-yl-2-pyridinyl)-1,3-benzoxazole;2-pyridin-2-yl-4-[6-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine;2-pyridin-2-yl-4-[7-(4-pyridin-2-yl-1,3,5-triazin-2-yl)phenanthren-2-yl]-1,3,5-triazine is sourced from PubChem (CID 159855896), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).